ToxStrategies Acquires Modality Solutions
ToxStrategies LLC is excited to announce that Modality Solutions is joining forces with our firm, greatly expanding our ability to serve the evolving needs of… read more
Latest News
EpidStrategies scientists present at ICPE 2023, Halifax Nova Scotia, August 23-27
EpidStrategies is excited to be attending and presenting at The International Society for Pharmacoepidemiology’s (ISPE) 39th Annual Meeting (ICPE 2023), August 23rd through… read more
EpidStrategies’ Scientists Support ASPN Award-Winning Abstract
Congratulations to our colleagues at NeuraLace Medical for receiving the Best Abstract Award from the American Society of Pain & Neuroscience (ASPN) 2023… read more
EpidStrategies’ Cara Frankenfeld will be at the American Society for Nutrition’s Annual Meeting, Nutrition 2023, in Boston, July 22-25
Dr. Frankenfeld is an expert in nutritional epidemiology research and has conducted primary data collection research and secondary data analysis using population-based data… read more
EpidStrategies’ Naomi Sacks is at ISPOR
Dr. Sacks is a co-author on four poster presentations at the annual meeting of ISPOR (The Professional Society for Health Economics and Outcomes… read more
Scientists from EpidStrategies are attending ISPOR 2023 in Boston!
Scientists from EpidStrategies are attending ISPOR 2023 in Boston! Please reach out and connect with us and meet the newest addition to our… read more
EpidStrategies Researchers Are Presenting at the 2023 Pediatric Academic Societies Meeting
EpidStrategies, a division of ToxStrategies LLC, is excited to announce that Mina Suh, Naimisha Movva, Xiaohui Jiang, Sue Pastula, and Heidi Reichert, along… read more
Systematic review article accepted for publication
A publication titled, “Benefit-Risk of Coffee Consumption and All-Cause Mortality: A Systematic Review and Disability Adjusted Life Year Analysis,” by ToxStrategies authors Candace… read more